1018 related articles for article (PubMed ID: 35488966)
1. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study.
Yuan S; Chen J; Li X; Fan R; Arsenault B; Gill D; Giovannucci EL; Zheng JS; Larsson SC
Eur J Epidemiol; 2022 Jul; 37(7):723-733. PubMed ID: 35488966
[TBL] [Abstract][Full Text] [Related]
2. The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study.
Xie J; Huang H; Liu Z; Li Y; Yu C; Xu L; Xu C
Hepatology; 2023 Mar; 77(3):949-964. PubMed ID: 35971878
[TBL] [Abstract][Full Text] [Related]
3. Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study.
Yuan S; Larsson SC
Eur J Epidemiol; 2022 Jul; 37(7):747-754. PubMed ID: 35119566
[TBL] [Abstract][Full Text] [Related]
4. Causal relationship between sleep apnea and non-alcoholic fatty liver disease: A Mendelian randomization study.
Zhang Z; Li M; Ji G; Zhang L
Eur J Clin Invest; 2024 Mar; 54(3):e14116. PubMed ID: 37916519
[TBL] [Abstract][Full Text] [Related]
5. Causal Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Peripheral Artery Disease: A Mendelian Randomization Approach.
Hoek AG; van Oort S; Elders PJM; Beulens JWJ
J Am Heart Assoc; 2022 Aug; 11(16):e025644. PubMed ID: 35929454
[TBL] [Abstract][Full Text] [Related]
6. Blood Levels of the
Ghodsian N; Gagnon E; Bourgault J; Gobeil É; Manikpurage HD; Perrot N; Girard A; Mitchell PL; Arsenault BJ
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959760
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.
Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC
Am J Clin Nutr; 2022 Dec; 116(6):1595-1609. PubMed ID: 36205540
[TBL] [Abstract][Full Text] [Related]
8. Mendelian-randomization study revealed causal relationship between nonalcoholic fatty liver disease and osteoporosis/fractures.
Pei X; Jiang W; Li L; Zeng Q; Liu CH; Wang M; Chen E; Zhou T; Tang H; Wu D
J Gastroenterol Hepatol; 2024 May; 39(5):847-857. PubMed ID: 38240493
[TBL] [Abstract][Full Text] [Related]
9. Diet, Lifestyle Behaviours and Other Risk Factors Associated With Type 2 Diabetes Beyond Body Mass Index: A Mendelian Randomization Study.
Jia Y; Guo D; Sun L; Shi M; Zhang K; Yang P; Zang Y; Wang Y; Liu F; Chen GC; Zhang Y; Zhu Z
Can J Diabetes; 2022 Dec; 46(8):822-828. PubMed ID: 35835669
[TBL] [Abstract][Full Text] [Related]
10. Obesity, Type 2 Diabetes, Lifestyle Factors, and Risk of Gallstone Disease: A Mendelian Randomization Investigation.
Yuan S; Gill D; Giovannucci EL; Larsson SC
Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e529-e537. PubMed ID: 33418132
[TBL] [Abstract][Full Text] [Related]
11. Role of Inflammatory Factors in Mediating the Effect of Lipids on Nonalcoholic Fatty Liver Disease: A Two-Step, Multivariable Mendelian Randomization Study.
Chen J; Zhou H; Jin H; Liu K
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297117
[TBL] [Abstract][Full Text] [Related]
12. Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study.
Chen L; Fan Z; Sun X; Qiu W; Mu W; Chai K; Cao Y; Wang G; Lv G
Hepatol Int; 2023 Apr; 17(2):326-338. PubMed ID: 36352064
[TBL] [Abstract][Full Text] [Related]
13. Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study.
Wang YB; Yang L; Deng YQ; Yan SY; Luo LS; Chen P; Zeng XT
J Transl Med; 2022 Oct; 20(1):495. PubMed ID: 36309747
[TBL] [Abstract][Full Text] [Related]
14. Association of Cardiovascular Risk Factors and Lifestyle Behaviors With Hypertension: A Mendelian Randomization Study.
van Oort S; Beulens JWJ; van Ballegooijen AJ; Grobbee DE; Larsson SC
Hypertension; 2020 Dec; 76(6):1971-1979. PubMed ID: 33131310
[TBL] [Abstract][Full Text] [Related]
15. Metabolic and lifestyle factors in relation to senile cataract: a Mendelian randomization study.
Yuan S; Wolk A; Larsson SC
Sci Rep; 2022 Jan; 12(1):409. PubMed ID: 35013517
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study.
Zhou BG; Xia JL; Jiang X; Ding YB; She Q
BMC Endocr Disord; 2024 Mar; 24(1):40. PubMed ID: 38504196
[TBL] [Abstract][Full Text] [Related]
17. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
Tuo L; Yan LT; Liu Y; Yang XX
Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.
Au Yeung SL; Borges MC; Wong THT; Lawlor DA; Schooling CM
Int J Epidemiol; 2023 Jun; 52(3):921-931. PubMed ID: 36367831
[TBL] [Abstract][Full Text] [Related]
19. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
[TBL] [Abstract][Full Text] [Related]
20. Causal effect of adiposity on the risk of 19 gastrointestinal diseases: a Mendelian randomization study.
Kim MS; Song M; Kim S; Kim B; Kang W; Kim JY; Myung W; Lee I; Do R; Khera AV; Won HH
Obesity (Silver Spring); 2023 May; 31(5):1436-1444. PubMed ID: 37014069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
